Vir Biotechnology (VIR) Current Assets (2018 - 2026)

Vir Biotechnology has disclosed Current Assets across 9 years of filings, most recently posting $523.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $523.0 million, down 43.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $523.0 million (down 43.9% YoY), and the FY2025 annual result was $514.1 million, down 50.69% from the prior year.
• Current Assets came in at $523.0 million for Q1 2026 at Vir Biotechnology, up from $514.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.6 billion in Q1 2022 to a low of $514.1 million in Q4 2025.
• The 5-year median for Current Assets is $1.2 billion (2024), against an average of $1.5 billion.
• Across the five-year window, Current Assets soared 165.37% in 2022 and slumped 50.69% in 2025, its largest moves.
• Vir Biotechnology's Current Assets stood at $2.5 billion in 2022, then slumped by 36.95% to $1.6 billion in 2023, then slumped by 34.36% to $1.0 billion in 2024, then plunged by 50.69% to $514.1 million in 2025, then grew by 1.73% to $523.0 million in 2026.
• The last three Current Assets figures came in at $523.0 million (Q1 2026), $514.1 million (Q4 2025), and $545.7 million (Q3 2025), per Business Quant data.